TMEM175 and Parkinson disease: Accordingly, small molecules aimed at increasing TMEM175 function might mitigate lysosomal dysfunction in PD patients with TMEM175 mutations but also in cases of neurodegenerative disease phenotypes caused, for example, by other endolysosomal gene defects.